Characterization of cells and gene-targeted mice deficient for the p53-binding kinase homeodomain-interacting protein kinase 1 (HIPK1)

被引:63
|
作者
Kondo, S
Lu, Y
Debbas, M
Lin, AW
Sarosi, I
Itie, A
Wakeham, A
Tuan, J
Saris, C
Elliott, G
Ma, WL
Benchimol, S
Lowe, SW
Mak, TW
Thukral, SK
机构
[1] Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada
[2] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[4] Amgen Inc, Thousand Oaks, CA 91320 USA
[5] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA
关键词
D O I
10.1073/pnas.0530308100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The tumor suppressor p53 is regulated in part by binding to cellular proteins. We used p53 as bait in the yeast two-hybrid system and isolated homeodomain-interacting protein kinase 1 (HIPK1) as a p53-binding protein. Deletion analysis showed that amino acids 100-370 of p53 and amino acids 885-1093 of HIPK1 were sufficient for HIPK1-p53 interaction. HIPK1 was capable of autophosphorylation and specific serine phosphorylation of p53. The HIPK1 gene was highly expressed in human breast cancer cell lines and oncogenically transformed mouse embryonic fibroblasts. HIPK1 was localized to human chromosome band 1p13, a site frequently altered in cancers. Gene-targeted HIPK1-/- mice were grossly normal but oncogenically transformed HIPK1-/- mouse embryonic fibroblasts exhibited reduced transcription of Mdm2 and were more susceptible than transformed HIPK1+/+ cells to apoptosis induced by DNA damage. Carcinogen-treated HIPK1-/- mice developed fewer and smaller skin tumors than HIPK1+/+ mice. HIPK1 may thus play a role in tumorigenesis, perhaps by means of the regulation of p53 and/or Mdm2.
引用
收藏
页码:5431 / 5436
页数:6
相关论文
共 50 条
  • [1] Homeodomain-interacting Protein Kinase 1 (HIPK1) Expression in Breast Cancer Tissues
    Park, Byeong-Woo
    Park, Seho
    Koo, Ja Seung
    Kim, Seung Il
    Park, Ji Min
    Cho, Jung Hoon
    Park, Hyung Seok
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 42 (12) : 1138 - 1145
  • [2] Homeodomain Interacting Protein Kinase 1 (HIPK1) Binds O-GlcNAc Transferase and is O-GlcNAcylated
    Copeland, Ronald
    Hart, Gerald
    FASEB JOURNAL, 2008, 22
  • [3] Ubiquitination and degradation of homeodomain-interacting protein kinase 2 (HIPK2) by WSB-1
    Choi, Cheol Yong
    Lee, Deresa
    FASEB JOURNAL, 2007, 21 (06): : A985 - A985
  • [4] TP53INP1s and homeodomain-interacting protein kinase-2 (HIPK2) are partners in regulating p53 activity
    Tomasini, R
    Samir, AA
    Carrier, A
    Isnardon, D
    Cecchinelli, B
    Soddu, S
    Malissen, B
    Dagorn, JC
    Iovanna, JL
    Dusetti, NJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37722 - 37729
  • [5] Novel homeodomain-interacting protein kinase family member, HIPK4, phosphorylates human p53 at serine 9
    Arai, Shigeki
    Matsushita, Akio
    Du, Kun
    Yagi, Ken
    Okazaki, Yasushi
    Kurokawa, Riki
    FEBS LETTERS, 2007, 581 (29): : 5649 - 5657
  • [6] Overlapping roles for homeodomain-interacting protein kinases Hipk1 and Hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals
    Isono, K
    Nemoto, K
    Li, YY
    Takada, Y
    Suzuki, R
    Katsuki, M
    Nakagawara, A
    Koseki, H
    MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (07) : 2758 - 2771
  • [7] Covalent modification of the homeodomain-interacting protein kinase 2 (HIPK2) by the ubiquitin-like protein SUMO-1
    Kim, YH
    Choi, CY
    Kim, Y
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) : 12350 - 12355
  • [8] Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
    Thomas G. Hofmann
    Andreas Möller
    Hüseyin Sirma
    Hanswalter Zentgraf
    Yoichi Taya
    Wulf Dröge
    Hans Will
    M. Lienhard Schmitz
    Nature Cell Biology, 2002, 4 : 1 - 10
  • [9] Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2
    Hofmann, TG
    Möller, A
    Sirma, H
    Zentgraf, H
    Taya, Y
    Dröge, W
    Will, H
    Schmitz, ML
    NATURE CELL BIOLOGY, 2002, 4 (01) : 1 - 10
  • [10] PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains
    Möller, A
    Sirma, H
    Hofmann, TG
    Rueffer, S
    Klimczak, E
    Dröge, W
    Will, H
    Schmitz, ML
    CANCER RESEARCH, 2003, 63 (15) : 4310 - 4314